UNITED THERAPEUTICS Corp 4

Director Christopher Causey received an annual non-employee director equity award of 2,380 shares of United Therapeutics Corp common stock on July 22, 2026.

On July 22, 2026, United Therapeutics Corp non-employee director Christopher Causey received an annual equity grant of 2,380 shares of common stock as a stock option/award with an exercise price of $0.00, reflecting a routine director compensation grant that will vest in full on the earlier of June 25, 2027 (the anticipated next annual shareholder meeting) or the one-year anniversary of the grant date. Following this award, Causey directly holds 4,190 shares of United Therapeutics common stock. As no market price data was provided, the transaction value and post-transaction holdings value are estimated based on the zero exercise price but cannot be quantified in dollar terms from the filing alone.

Filing Facts

CIK

1082554

Ticker

UTHR

Form

4

Source Type

fda

Accession

0001237334-26-000006

Alert Tier

5